These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4180547)

  • 1. Heparin and protamine in graft rejection.
    Di Perri T; Grossi A; Auteri A
    Lancet; 1969 Apr; 1(7600):888. PubMed ID: 4180547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of the hematic level of complement in animals with skin homografts treated with heparin and protamine sulfate].
    Di Perri T; Grossi A; Auteri A; Rocco F
    Boll Soc Ital Biol Sper; 1969 May; 45(10):682-5. PubMed ID: 4923648
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-protamine in prevention of graft rejection.
    Di Perri T; Grosse A; Auteri A
    Lancet; 1972 Jan; 1(7740):45. PubMed ID: 4108848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of heparin and protamine sulfate on serum complement activity and on rejection phenomenon in experimental skin heterotransplants].
    Di Perri T; Grossi A; Auteri A; Carli A; Rocco F
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1083-5. PubMed ID: 4911886
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental hormones and graft rejection.
    Hulka JF; Mohr K
    Am J Obstet Gynecol; 1969 Jul; 104(6):889-92. PubMed ID: 4893387
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.
    Rent R; Ertel N; Eisenstein R; Gewurz H
    J Immunol; 1975 Jan; 114(1 Pt 1):120-4. PubMed ID: 234494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of heparin and protamine sulfate on the level of hematic complement evaluated with the immuno-hemolysis method. Studies in vivo].
    Di Perri T; Grossi A; Auteri A; Rocco F
    Boll Soc Ital Biol Sper; 1969 May; 45(10):677-9. PubMed ID: 5399985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive action of rifampicin].
    Serrou B; Solassol C; Karcenty L; Joyeux H; Pujol H
    Nouv Presse Med; 1972 May; 1(19):1295. PubMed ID: 4554692
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of skin xenograft survival by L-asparaginase.
    Etheredge EE; Shons A; Harris N; Najarian JS
    Transplantation; 1971 Mar; 11(3):353-4. PubMed ID: 4934269
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral antibody in allograft reactions.
    Winn HJ
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in the science of transplantation. Diagnosis of rejection of a kidney allotransplant in men].
    Jelińska S
    Pol Arch Med Wewn; 1970 Jun; 44(6):667-71. PubMed ID: 4393693
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of chondroitin sulfate in prolonging survival of adult skin allografts.
    Ashby MW; Thomson AR; Nosé Y
    J Surg Res; 1971 Jul; 11(7):350-5. PubMed ID: 4945866
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in serum complement and fucose after skin grafting in guinea pigs.
    Coppola ED; Villegas GR; Rosato FE
    J Surg Res; 1968 Jul; 8(7):308-13. PubMed ID: 4873860
    [No Abstract]   [Full Text] [Related]  

  • 14. The xenograft rejection phenomenon. II. Response of the guinea pig to mouse, rat and rabbit skin xenografts.
    Ben-Hur N; Solowey AC; Rapaport FT
    Isr J Med Sci; 1969; 5(3):322-31. PubMed ID: 4898220
    [No Abstract]   [Full Text] [Related]  

  • 15. The early effects of alloantibody and complement on rat kidney allografts.
    French ME
    Transplantation; 1972 May; 13(5):447-51. PubMed ID: 4557794
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral factors in experimental renal allograft and xenograft rejection.
    Chavez-Peon F; Monchik G; Winn HJ; Russell PS
    Transplant Proc; 1971 Mar; 3(1):573-6. PubMed ID: 4937941
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histaminase release by heparin and protamine in guinea pigs].
    Hahn F; Schmutzler W; Seseke G; Giertz H; Bernauer W
    Biochem Pharmacol; 1966 Feb; 15(2):155-60. PubMed ID: 4957539
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions.
    Gewurz H; Clark DS; Cooper MD; Varco RL; Good RA
    Transplantation; 1967 Sep; 5(5):1296-303. PubMed ID: 4862841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of the heparin-protamine complex on serum complement. Research in vitro and in vivo].
    Di Perri T; Grossi A; Auteri A
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1085-7. PubMed ID: 5374944
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolongation of skin graft survival and induction of resistance to infection by phytohemagglutinin.
    Markley K; Thornton S; Smallman E; Markley P
    Transplantation; 1969 Sep; 8(3):258-64. PubMed ID: 4985393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.